Urinary Leukotriene <scp> E <sub>4</sub> </scp> Enables Rule‐In Diagnosis of <scp>NSAID</scp> ‐Exacerbated Respiratory Disease

The data that support the findings of this study are available from the corresponding author upon reasonable request. Figure S1: Study flow diagram. N-ERD, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; NT-CRSwNP, NSAID-tolerant chronic rhinosinusitis with nasal polyps. Table S1: Baseline demographic characteristics of the discovery and validation cohorts. Table S2: Diagnostic performance of urinary LTE4 for identification of N-ERD in the validation cohort at two cutoff values. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
Allergy
Published
2026-07-23
DOI
https://doi.org/10.1111/all.70458
Primary Topic
Drug-Induced Adverse Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of NSAID ‐Exacerbated Respiratory Disease

Patrick M. Vanderboom, Rijul S. Kshirsagar, Sergio E. Chiarella, M. A. Vorobjeva et al.
Allergy
Drug-Induced Adverse Reactions
article

Urinary Leukotriene E 4 Enables Rule‐In Diagnosis of NSAID ‐Exacerbated Respiratory Disease

Patrick M. Vanderboom, Rijul S. Kshirsagar, Sergio E. Chiarella, M. A. Vorobjeva, Diane E. Grill, Hamid R. Tizhoosh, Erin K. O’Brien, Hirohito Kita, Kimberly G. Blumenthal, Katherine N. Cahill, C.‐C. Chen, Masaki Orihara, Rohit Divekar, Anthony D. Maus, Janalee K. Stokken, Jacob G. Eide, Elina Jerschow, Golda Hudes, Aleksandr iAkushev, Alessandra Tomasello, Nadeem Akbar, Kayla Moehnke, Patrick Colley
article en

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request. Figure S1: Study flow diagram. N-ERD, nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; NT-CRSwNP, NSAID-tolerant chronic rhinosinusitis with nasal polyps. Table S1: Baseline demographic characteristics of the discovery and validation cohorts. Table S2: Diagnostic performance of urinary LTE4 for identification of N-ERD in the validation cohort at two cutoff values. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Allergy
Albert Einstein College of Medicine (US), Mayo Clinic (US), Montefiore Medical Center (US), Jacksonville College (US), WinnMed (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), Vanderbilt University Medical Center (US)
Mayo Clinic, National Institute of Allergy and Infectious Diseases
Zero hunger
Openalex Percentile: Top 10%
Drug-Induced Adverse Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.